Twist Bioscience stock edges higher with price holding above key support despite seller pressure

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 0.43% today

Highlights

TWST trades below short-term resistance after a 3.43% weekly decline, with sellers applying near-term pressure.
Momentum signals are mixed—MACD flashes strong buy, but RSI and price weakness suggest potential for further downside.
Price is expected to consolidate between $80.00 and $93.50, with a bullish breakout targeting $96.00 if resistance breaks.

Twist Bioscience released a link to an article titled 'As the Science of MRD Settles, Operational Challenges Mount.' The company stated this provides the latest information regarding MRD.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Seller pressure persists as medium-term trend and support hold

TWST is trading at $86.91, below the MA-20 at $93.74 but still above the MA-50 at $80.40 and well above the MA-200 at $51.43. This setup signals near-term pressure from sellers, a still-intact medium-term trend, and robust long-term support. The Ichimoku Kijun (D1) at $93.48 sits above the current price, now acting as immediate resistance. Near-term support is identified at the MA-50 ($80.40), with key support at the MA-100 ($66.25). Immediate resistance is set at the Ichimoku Kijun ($93.48), followed by key resistance at the MA-20 ($93.74).

Mixed momentum and oversold signals amid weekly price drop

Momentum signals on D1 are mixed: MACD gives a strong buy, and ADX suggests active trend strength. However, RSI at 46.87 signals near-term downside momentum, while oversold flags from Stoch RSI and CCI show possible exhaustion among sellers. BBP on D1 indicates an overbought reading (3.71), reflecting lingering dominance by buyers despite the weekly retreat. Over the past week, TWST has fallen $3.36 (3.43%), down from $90.27, and now trades at the very bottom of the weekly range—near recent support—while weekly volatility stands at 14.65%. The tone is one of steady decline from the weekly high, with momentum indicators diverging from the sharp short-term drawdown.

Upside bias as historical support contains bearish scenario

Looking ahead, the expected price range for the coming week is $80.00 to $96.00, adjusted for recent volatility and anchored around the current price; this sits above the 52-week low of $23.30 and within reach of the 52-week high of $105.41. With W1 and D1 indicators showing 4 out of 4 core signals as "Buy" or "Strong Buy" (RSI, ADX, MACD, MA-50), the probability of price increase is very high (greater than 80%), leaving a very low chance of a continued decline. The baseline scenario is consolidation between $80.00 and $93.50. In a bullish case, a break above $93.50 could open a move toward $96.00. If bearish momentum intensifies and support at $80.00 breaks, a retest of lower levels closer to the MA-100 ($66.25) becomes more likely, though year-to-date gains suggest longer-term buyers remain supportive.

Previously it was reported that Twist Bioscience maintained a bullish long-term trend, though facing near-term corrective pressure as key technical levels guided investor sentiment. Building on this, the current outlook emphasizes the importance of monitoring upcoming catalysts, with traders advised to watch for decisive moves around major support and resistance zones.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.